(Q45346373)
Statements
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact (English)
Marco Volante
Mauro Papotti
Gianni Bussolati
Manoj Gandhi
Yuri E Nikiforov
16 October 2009